Developability assessment or preformulation studies of small molecule is an important part of drug discovery process leading to selection of New Chemical Entities (NCEs) for clinical studies.

GVK BIO is equipped with capabilities to support developability assessment of NCEs with limited amount of material and quick turnaround of time. GVK BIO is also equipped with capabilities to develop formulations for Phase I - III clinical stages for conventional formulations like tablets, capsules, oral liquids, injectables, semisolids and enabling formulations like microemusion, solid dispersion and nanosuspension.

Download our whitepaper to understand Need, Process & Our Capabilities in Developability Assessment.

Developability Assessment of Small Molecules

© 2019 GVK Biosciences Private Limited. All Rights Reserved
Terms & Conditions | Privacy Policy | Privacy Notice - Customers/Vendors/Job Applicants

Please complete the form to download